Clinical Trials Directory

Trials / Conditions / Fibrolamellar Hepatocellular Carcinoma

Fibrolamellar Hepatocellular Carcinoma

5 registered clinical trials studyying Fibrolamellar Hepatocellular Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingDRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Ca
NCT06027086
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 / Phase 2
UnknownTherapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
NCT05681949
Charite University, Berlin, GermanyN/A
RecruitingFusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
NCT05937295
University Hospital TuebingenPhase 1
WithdrawnSequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocell
NCT02702960
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
TerminatedStudy of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
NCT01215565
Assistance Publique - Hôpitaux de ParisPhase 2